论文部分内容阅读
酮基布洛芬(ketoprofen)鉴定会于1984年9月1～3日在重庆召开。参加这次会议的有中国医药工业公司、重庆市科委、重庆市卫生局、重庆药检所、四川医学院、上海医药情报中心站、重庆医学院附属医院、第三军医大学附属医院、重庆医药工业研究所等31个单位的60多名代表。 酮基布洛芬是国外近年来发明并迅速发展的新药,它治疗风湿性关节炎、脊椎炎、外伤及手术后的抗炎镇痛,疗效显著。西南合成制药厂接受了国家医药管理局下达的这项重大科研任务,研制成了
Identification of ketoprofen will be held in Chongqing from September 1 to September 3, 1984. Attend this meeting, there are China Pharmaceutical Industry Corporation, Chongqing Municipal Science and Technology Commission, Chongqing Municipal Health Bureau, Chongqing Institute for Drug Control, Sichuan Medical College, Shanghai Medical Intelligence Center Station, Chongqing Medical College Hospital, Third Military Medical University Hospital, Chongqing Pharmaceutical Industrial Institute and other 31 units of more than 60 representatives. Ketoprofen is a new drug invented and developed rapidly in recent years in the world. It treats rheumatoid arthritis, spondylitis, trauma and post-operative anti-inflammatory and analgesic effects. Southwest Synthetic Pharmaceutical Factory accepted the State Medical Administration issued this major research task, developed